Correction to: Nature Reviews Gastroenterology & Hepatology https://doi.org/10.1038/s41575-023-00793-0. Published online 23 May 2023.
In the version of this article originally published online, there was an error in the seventh paragraph: in the text now reading “Additionally, the half-life of etrasimod is shorter than ozanimod (~30 hours versus up to 11 days),” the half-life of etrasimod was originally given as “11 hours”. The error has been corrected in the HTML and PDF versions of the article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Matsuoka, K., Hibi, T. Author Correction: Etrasimod for ulcerative colitis: evaluating phase III results. Nat Rev Gastroenterol Hepatol 20, 829 (2023). https://doi.org/10.1038/s41575-023-00817-9
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41575-023-00817-9
